Study Stopped
pandemic
Gastric Electrical Stimulation for Abdominal Pain in Gastroparesis
1 other identifier
observational
4
1 country
1
Brief Summary
To conduct a pilot study to evaluate the effects of new GES programming settings on abdominal pain in patients with gastroparesis and existing GES devices, whose abdominal pain has so far been refractory to drugs and/or devices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2019
CompletedFirst Posted
Study publicly available on registry
October 9, 2019
CompletedStudy Start
First participant enrolled
December 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2020
CompletedOctober 27, 2023
October 1, 2023
3 months
October 4, 2019
October 24, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Abdominal Pain
Abdominal Pain by Brief Pain Inventory. The values are 0-10, with 10 being worse outcome.
4 weeks
Study Arms (1)
Gastroparesis patients with abdominal pain
Patients with gastroparesis who have had an Enterra device in place for at least two months who continue to have moderate to severe abdominal pain.
Interventions
To measure validated and subjective pain scores among patients with an existing GES device, and who have a trial of new settings directed at abdominal pain and compare their pain scores to each patient baseline symptoms, done with their previous GES settings.
Eligibility Criteria
Gastroparesis patients with abdominal pain.
You may qualify if:
- Should be able to give informed consent for the study
- Has Enterra GES device in place for at least 2 months
- Continue to have moderate to severe abdominal pain on at least one pain questionnaire or \>5 score (on a scale of 0-10 for pain) on the VAS questionnaire for at least 2 months.
- Abdominal pain should be either persistent; for example, daily for at least \>1 hour, be chronic for \>2 months, and refractory to original Enterra GES settings
You may not qualify if:
- Unable to provide informed consent
- Pregnancy
- Any other active health problems that would render patient unable to complete the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Louisville
Louisville, Kentucky, 40202, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Abell, MD
University of Louisville
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 4, 2019
First Posted
October 9, 2019
Study Start
December 18, 2019
Primary Completion
March 13, 2020
Study Completion
March 13, 2020
Last Updated
October 27, 2023
Record last verified: 2023-10